Managing Intellectual Property BlogAugust 11, 2016
The Federal Circuit limits the reach of the on sale bar and provides guidance to pharmaceutical companies that rely on the use of contract manufacturers. Bruce Haas and Lauren Zuffante discuss.
View Attachment (PDF)
(212) 218-2100 New York
(714) 540-8700 California
(202) 530-1010 Washington DC
© Copyright 2018 Fitzpatrick, Cella, Harper & Scinto. All Rights Reserved. Images are for design purposes only with actors appearing in some photos. Attorney Advertising. Prior results do not guarantee similar outcome.